The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1
Open accessAbstract
The family of cytoplasmic Janus (Jak) tyrosine kinases plays an essential role in cytokine signal transduction, regulating cell survival and gene expression. Ligand-induced receptor dimerization results in phosphorylation of Jak2 on activation loop tyrosine Y1007 and stimulation of its catalytic activity, which, in turn, results in activation of several downstream signaling cascades. Recently, the catalytic activity of Jak2 has been found to be subject to negative regulation through various mechanisms including association with SOCS proteins. Here we show that the ubiquitin-dependent proteolysis pathway is involved in the regulation of the turnover of activated Jak2. In unstimulated cells Jak2 was monoubiquitinated, and interleukin-3 or gamma interferon stimulation induced polyubiquitination of Jak2. The polyubiquitinated Jak2 was rapidly degraded through proteasomes. By using different Jak2 mutants we show that tyrosine-phosphorylated Jak2 is preferentially polyubiquitinated and degraded. Furthermore, phosphorylation of Y1007 on Jak2 was required for proteasomal degradation and for SOCS-1-mediated downregulation of Jak2. The proteasome inhibitor treatment stabilized the Jak2-SOCS-1 protein complex and inhibited the proteolysis of Jak2. In summary, these results indicate that the ubiquitin-proteasome pathway negatively regulates tyrosine-phosphorylated Jak2 in cytokine receptor signaling, which provides an additional mechanism to control activation of Jak2 and maintain cellular homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Self-citationThe ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408 · cited 1×
“One of the family members, SOCS-1, also termed JAB (Jak binding protein) or SSI-1 (STAT-induced STAT inhibitor 1), was identified through its ability to inhibit IL-6 signal transduction and bind to Jak2 (11, 34, 46).”
BackgroundProtein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,211
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762
Self-citationTwenty proteins containing a C-terminal SOCS box form five structural classes
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D., & Nicola, N. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.114 · Cited by 733
Self-citationYasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671
Zhang, J.-G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 627
Self-citationSignaling Through the Hematopoietic Cytokine Receptors
Ihle, J. N. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.369 · Cited by 612
Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Conaway, R. C., & Conaway, J. W. (1998) · Genes & Development · doi:10.1101/gad.12.24.3872 · Cited by 595 · cited 2×
“The association of SOCS proteins with elongins B and C has, however, raised the possibility that the SOCS-mediated regulation of cytokine signaling may also involve the proteasome pathway (21).”
BackgroundInhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M., & Klausner, R. D. (1995) · Science · doi:10.1126/science.7660122 · Cited by 568
SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality
Marine, J.-C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A., & Ihle, J. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80048-3 · Cited by 516
Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., & Ihle, J. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8429 · Cited by 501
Self-citationNicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J.-G., Silva, A., Asimakis, M., Farley, A., Nash, A. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100135197 · Cited by 456
Self-citationSubstrate Targeting in the Ubiquitin System
Laney, J. D., & Hochstrasser, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80752-7 · Cited by 449
Regulation of Interferon-γ-Activated STAT1 by the Ubiquitin-Proteasome Pathway
Kim, T. K., & Maniatis, T. (1996) · Science · doi:10.1126/science.273.5282.1717 · Cited by 401
Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
Self-citationSOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms
Ram, P. A., & Waxman, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35553 · Cited by 361
Feng, J., Witthuhn, B. A., Matsuda, T., Kohlhuber, F., Kerr, I. M., & Ihle, J. N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2497 · Cited by 356
Haspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312 · cited 1×
“For example, STAT1 becomes ubiquitinated after IFN- stimulation in HeLa cells (24), and tyrosine-phosphorylated Stat1 has been found to be stabilized by proteasome inhibitors in fibroblasts without any indication of ubiquitination (16).”
BackgroundThe SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010074200 · Cited by 311 · cited 1×
“Recently SOCS-1 was shown to mediate the growth inhibition of TEL-Jak2-transformed cells and to accelerate the proteasomal degradation of the oncogenic, hyperactive TEL-Jak2 and gyrase B-Jak2 chimeras, neither of which is activated in response to cytokines (13, 20).”
BackgroundStrous, G. J., van Kerkhof, P., Govers, R., Ciechanover, A., & Schwartz, A. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00754.x · Cited by 303
Deubiquitinating Enzymes: A New Class of Biological Regulators
D'Andrea, A., & Pellman, D. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204251 · Cited by 271
Cohney, S. J., Sanden, D., Cacalano, N. A., Yoshimura, A., Mui, A., Migone, T. S., & Johnston, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4980 · Cited by 265
Narazaki, M., Fujimoto, M., Matsumoto, T., Morita, Y., Saito, H., Kajita, T., Yoshizaki, K., Naka, T., & Kishimoto, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13130 · Cited by 239
Src-catalyzed Phosphorylation of c-Cbl Leads to the Interdependent Ubiquitination of Both Proteins
Yokouchi, M., Kondo, T., Sanjay, A., Houghton, A., Yoshimura, A., Komiya, S., Zhang, H., & Baron, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102219200 · Cited by 213
Verdier, F., Chrétien, S., Muller, O., Varlet, P., Yoshimura, A., Gisselbrecht, S., Lacombe, C., & Mayeux, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28185 · Cited by 193
Zhang, J.-G., Metcalf, D., Rakar, S., Asimakis, M., Greenhalgh, C., Willson, T., Starr, R., Nicholson, S., Carter, W., Alexander, W., et al. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.231486498 · Cited by 189
Self-citationRegulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
Oda, H., Kumar, S., & Howley, P. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9557 · Cited by 177
Frantsve, J., Schwaller, J., Sternberg, D. W., Kutok, J., & Gilliland, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3547-3557.2001 · Cited by 171
Kim, H., & Baumann, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5326 · Cited by 170
Suppressor of Cytokine Signaling-1 Inhibits VAV Function through Protein Degradation
De Sepulveda, P., Ilangumaran, S., & Rottapel, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000106200 · Cited by 167
SOCS proteins, regulators of intracellular signaling.
Chen, X.-P., Losman, J., & Rothman, P. (2000) · Immunity · doi:10.1016/s1074-7613(00)00028-5 · Cited by 162
Ubiquitin-mediated degradation of active Src tyrosine kinase
Harris, K. F., Shoji, I., Cooper, E. M., Kumar, S., Oda, H., & Howley, P. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13738 · Cited by 161
Wang, D., Moriggl, R., Stravopodis, D. J., Carpino, N., Marine, J., Teglund, S., Feng, J., & Ihle, J. N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.392 · Cited by 135
Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction
Alexander, W., Starr, R., Metcalf, D., Nicholson, S., Farley, A., Elefanty, A., Brysha, M., Kile, B., Richardson, R., Baca, M., et al. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.4.588 · Cited by 134
Self-citationA dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling
Yeh, T. C., Dondi, E., Uzé, G., & Pellegrini, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160130297 · Cited by 130
Involvement of Proteasomes in Regulating Jak-STAT Pathways upon Interleukin-2 Stimulation
Yu, C., & Burakoff, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14017 · Cited by 128
Different protein turnover of interleukin‐6‐type cytokine signalling components
Siewert, E., Müller‐Esterl, W., Starr, R., Heinrich, P. C., & Schaper, F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00719.x · Cited by 121
Verdier, F., Walrafen, P., Hubert, N., Chrétien, S., Gisselbrecht, S., Lacombe, C., & Mayeux, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.24.18375 · Cited by 105
Brysha, M., Zhang, J.-G., Bertolino, P., Corbin, J. E., Alexander, W. S., Nicola, N. A., Hilton, D. J., & Starr, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102737200 · Cited by 102
Self-citationNyman, T. A., Matikainen, S., Sareneva, T., Julkunen, I., & Kalkkinen, N. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01433.x · Cited by 95
The proteasome: a protein‐destroying machine
Tanaka, K., & Chiba, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00207.x · Cited by 91
Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1
Metcalf, D., Alexander, W., Elefanty, A., Nicola, N., Hilton, D., Starr, R., Mifsud, S., & di Rago, L. (1999) · Leukemia · doi:10.1038/sj.leu.2401440 · Cited by 84
Self-citationInterleukin-3–Induced Activation of the JAK/STAT Pathway Is Prolonged by Proteasome Inhibitors
Callus, B. A., & Mathey-Prévôt, B. (1998) · Blood · doi:10.1182/blood.v91.9.3182 · Cited by 81
E2/E3-mediated Assembly of Lysine 29-linked Polyubiquitin Chains
Mastrandrea, L. D., You, J., Niles, E. G., & Pickart, C. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27299 · Cited by 77
Termination of growth hormone pulse-induced STAT5b signaling.
Gebert, C., Park, S.-H., & Waxman, D. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0235 · Cited by 76
Yen, C.-H., Yang, Y., Ruscetti, S. K., Kirken, R. A., Dai, R. M., & Li, C.-C. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6372 · Cited by 57
Kovanen, P., Junttila, I., Takaluoma, K., Saharinen, P., Valmu, L., Li, W.-Q., & Silvennoinen, O. (2000) · Blood · doi:10.1182/blood.v95.5.1626.005k21_1626_1632 · Cited by 53
Self-citationCytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors
Silvennoinen, O., Saharinen, P., Paukku, K., Takaluoma, K., & Kovanen, P. E. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb05047.x · Cited by 33
Self-citation
Cited by
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1226 · Cited by 1,372
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Seif, F., Khoshmirsafa, M., Aazami, H., Mohsenzadegan, M., Sedighi, G., & Bahar, M. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0177-y · Cited by 768
Alexander, W. S., & Hilton, D. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.091003.090312 · Cited by 701
Self-citationRyo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Metadata
- Authors
- Ungureanu, D., Saharinen, P., Junttila, I., Hilton, D. J., & Silvennoinen, O.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-05-01
- Volume
- 22
- Issue
- 10
- Pages
- 3316-3326
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2098437309
- Cited by
- 260
- References
- 57
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.